SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Indications -- obesity/erectile dysfunction -- Ignore unavailable to you. Want to Upgrade?


To: Icebrg who wrote (102)4/15/2003 3:55:00 AM
From: Icebrg  Read Replies (1) | Respond to of 435
 
The New York Times carries an article on the off-label use of drugs to induce weight-loss.

Message 18841513

The drugs in question are J&J's Topamax and Elan's Zonegran. Both are according to their labels to be used for treatment of epilepsy.

Erik